These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31847)

  • 1. Behavior therapy, supportive psychotherapy, imipramine, and phobias.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1978 Mar; 35(3):307-16. PubMed ID: 31847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
    Zitrin CM; Klein DF; Woerner MG; Ross DC
    Arch Gen Psychiatry; 1983 Feb; 40(2):125-38. PubMed ID: 6337578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of short-term treatment regimens in phobic patients: a preliminary report.
    Zitrin CM; Klein DF; Lindemann C; Tobak P; Rock M; Kaplan JE; Ganz VH
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):233-50. PubMed ID: 4791
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
    Marks IM; Gray S; Cohen D; Hill R; Mawson D; Ramm E; Stern RS
    Arch Gen Psychiatry; 1983 Feb; 40(2):153-62. PubMed ID: 6130752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients?
    Klein DF; Zitrin CM; Woerner MG; Ross DC
    Arch Gen Psychiatry; 1983 Feb; 40(2):139-45. PubMed ID: 6130751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential treatment of phobias: use of imipramine for panic attacks.
    Zitrin CM
    J Behav Ther Exp Psychiatry; 1983 Mar; 14(1):11-8. PubMed ID: 6134756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of agoraphobia with group exposure in vivo and imipramine.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1980 Jan; 37(1):63-72. PubMed ID: 6101535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.
    Lelliott PT; Marks IM; Monteiro WO; Tsakiris F; Noshirvani H
    J Nerv Ment Dis; 1987 Oct; 175(10):599-605. PubMed ID: 3309186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF; Ross DC; Cohen P
    Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of agoraphobics after exposure and imipramine.
    Cohen SD; Monteiro W; Marks IM
    Br J Psychiatry; 1984 Mar; 144():276-81. PubMed ID: 6367875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically significant improvement in agoraphobia research.
    Mavissakalian M
    Behav Res Ther; 1986; 24(3):369-70. PubMed ID: 2873811
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in psychiatry. Panic attacks and phobias.
    Sheehan DV
    N Engl J Med; 1982 Jul; 307(3):156-8. PubMed ID: 7045660
    [No Abstract]   [Full Text] [Related]  

  • 15. Agoraphobics and social phobics: differences in background factors, syndrome profiles and therapeutic response.
    Persson G; Nordlund CL
    Acta Psychiatr Scand; 1985 Feb; 71(2):148-59. PubMed ID: 2858149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined pharmacological and behavioral treatment for agoraphobia.
    Telch MJ; Agras WS; Taylor CB; Roth WT; Gallen CC
    Behav Res Ther; 1985; 23(3):325-35. PubMed ID: 2860892
    [No Abstract]   [Full Text] [Related]  

  • 17. Two-year follow-up of exposure and imipramine treatment of agoraphobia.
    Mavissakalian M; Michelson L
    Am J Psychiatry; 1986 Sep; 143(9):1106-12. PubMed ID: 3529993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and combined therapy in panic states.
    Pecknold JC
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):97-104. PubMed ID: 2888162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
    Mavissakalian M; Michelson L; Dealy RS
    Br J Psychiatry; 1983 Oct; 143():348-55. PubMed ID: 6626853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M; Perel J
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.